Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosisJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1) [Peer Reviewed Journal]The Author(s) 2024 ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-023-05542-zDigital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Ultrasound-based deep learning radiomics nomogram for risk stratification of testicular masses: a two-center studyJournal of cancer research and clinical oncology, 2025-01, Vol.150 (1) [Peer Reviewed Journal]The Author(s) 2024 ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-023-05549-6Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Public Theology and Its Application: A Case Study of Goryeoin Ministry in South KoreaThe international journal of religion and spirituality in society, 2025, Vol.15 (1), p.57 [Peer Reviewed Journal]Copyright © 2024, Common Ground Research Networks, All Rights Reserved ;ISSN: 2154-8633 ;EISSN: 2154-8641 ;DOI: 10.18848/2154-8633/CGP/v15i01/57-73Full text available |
|
4 |
Material Type: Article
|
Sexual and preventive behaviors associated with HAV, HBV, and HPV vaccine hesitancy among men who have sex with men in FranceHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2348845-2348845 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2348845 ;PMID: 38783608Full text available |
|
5 |
Material Type: Article
|
Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling studyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2348839-2348839 [Peer Reviewed Journal]2024 GlaxoSmithKline. Published with license by Taylor & Francis Group, LLC. 2024 GlaxoSmithKline ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2348839 ;PMID: 38804600Full text available |
|
6 |
Material Type: Article
|
Herpes zoster in older adults: Impact on carbon footprint in the United StatesHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2335722-2335722 [Peer Reviewed Journal]2024 GSK. Published with license by Taylor & Francis Group, LLC. 2024 GSK ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2335722 ;PMID: 38698759Full text available |
|
7 |
Material Type: Article
|
Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and TanzaniaGlobal health action, 2024-12, Vol.17 (1), p.2345970-2345970 [Peer Reviewed Journal]EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2345970 ;PMID: 38774927Full text available |
|
8 |
Material Type: Article
|
Gender, age, and turnover intention among academic employees in higher education institutions in Addis Ababa, EthiopiaCogent social sciences, 2024-12, Vol.10 (1) [Peer Reviewed Journal]ISSN: 2331-1886 ;EISSN: 2331-1886 ;DOI: 10.1080/23311886.2023.2294560Full text available |
|
9 |
Material Type: Article
|
Human papillomavirus and occupational exposure: The need for vaccine provision for healthcare providersHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2342622-2342622 [Peer Reviewed Journal]2024 Mayo Foundation for Medical Education and Research. Published with license by Taylor & Francis Group, LLC. 2024 Mayo Foundation for Medical Education and Research ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2342622 ;PMID: 38771122Full text available |
|
10 |
Material Type: Article
|
Knowledge about, attitudes toward and acceptance and predictors of intention to receive the mpox vaccine among cancer patients in China: A cross-sectional surveyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2337157-2337157 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2337157 ;PMID: 38644633Full text available |
|
11 |
Material Type: Article
|
The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancerCancer biology & therapy, 2024-12, Vol.25 (1), p.2355705-2355705 [Peer Reviewed Journal]ISSN: 1538-4047 ;EISSN: 1555-8576 ;DOI: 10.1080/15384047.2024.2355705 ;PMID: 38778753Full text available |
|
12 |
Material Type: Article
|
Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteersHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2301631-2301631 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2023.2301631 ;PMID: 38189360Full text available |
|
13 |
Material Type: Article
|
Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysisHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2341454-2341454 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2341454 ;PMID: 38695296Full text available |
|
14 |
Material Type: Article
|
Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from LibyaLibyan journal of medicine, 2024-12, Vol.19 (1), p.2356906-2356906 [Peer Reviewed Journal]ISSN: 1993-2820 ;EISSN: 1819-6357 ;DOI: 10.1080/19932820.2024.2356906 ;PMID: 38785139Full text available |
|
15 |
Material Type: Article
|
Hypophysitis after COVID-19 vaccination in a patient with Rathke's cleft cyst: A case reportHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2297455-2297455 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2023.2297455 ;PMID: 38174857Full text available |
|
16 |
Material Type: Article
|
Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS studyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2350091-2350091 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2350091 ;PMID: 38757631Full text available |
|
17 |
Material Type: Article
|
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide surveyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2334084-2334084 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2334084 ;PMID: 38563792Full text available |
|
18 |
Material Type: Article
|
Modeling outbreaks of COVID-19 in China: The impact of vaccination and other control measures on curbing the epidemicHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2338953-2338953 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2338953 ;PMID: 38658178Full text available |
|
19 |
Material Type: Article
|
Exploring barriers to influenza vaccine uptake and recommendation among healthcare providers in the community in China: A qualitative studyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2352916-2352916 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2352916 ;PMID: 38744298Full text available |
|
20 |
Material Type: Article
|
Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional surveyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2310916-2310916 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2310916 ;PMID: 38369712Full text available |